Addendum: Low-value approvals and high prices might incentivize ineffective drug development
Crossref DOI link: https://doi.org/10.1038/s41571-018-0120-1
Published Online: 2018-11-12
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Prasad, Vinay
McCabe, Christopher
Mailankody, Sham
Text and Data Mining valid from 2018-11-12
Article History
First Online: 12 November 2018